SCHEMBL2567591

SCHEMBL2567591

CCN(CC)C(C)C(C)N(CC)CC

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.36
PGR P06401 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
HTR2A P28223 1/20 0.31
HRH1 P35367 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10284280 0.85 FDPS (0.33) FDPS
SCHEMBL25806850 0.85 FDPS (0.33) FDPS
SCHEMBL13417347 0.85 FDPS (0.33) FDPS
SCHEMBL13619005 0.79 FDPS (0.31) FDPS
SCHEMBL21489617 0.79 FDPS (0.31) FDPS
SCHEMBL9430761 0.79 FDPS (0.31) FDPS
SCHEMBL13612892 0.79 PGR (0.31) FDPSPGRADRA2AADRA2BHTR2A
SCHEMBL7881947 0.79 TSHR (0.37) FDPSPGRADRA2AADRA2BHTR2A
SCHEMBL18602945 0.79 PGR (0.31) FDPSPGRADRA2AADRA2BHTR2A
SCHEMBL13266482 0.79 FDPS (0.31) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8231997-B2 Electrolyte membrane-electrode membrane assembly for solid polymer fuel cell and production method thereof, and fuel cell equipped therewith TOKUYAMA CORPORATION (JP) 2012-07-31 US disclosed
EP-1965456-B1 ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER FUEL CELL, PROCESS FOR PRODUCING THE SAME, AND FUEL CELL COMPRISING SAID ASSEMBLY TOKUYAMA CORP (JP) 2011-11-02 EP disclosed
US-20090305110-A1 ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER TYPE FUEL CELL AND PRODUCTION METHOD THEREOF, AND FUEL CELL EQUIPPED THEREWITH TOKUYAMA CORPORATION (JP) 2009-12-10 US disclosed
EP-1965456-A1 ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER FUEL CELL, PROCESS FOR PRODUCING THE ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY, AND FUEL CELL COMPRISING THE ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY TOKUYAMA CORPORATION (JP) 2008-09-03 EP disclosed
US-20060019565-A1 Method for delivering biologically active substnces CIBA SPECIALTY CHEMICALS CORP. 2006-01-26 US disclosed
EP-1532310-A1 METHOD FOR DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES Ciba SC Holding AG (CH) 2005-05-25 EP disclosed
WO-2004020729-A1 METHOD FOR DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019565-A1 Method for delivering biologically active substnces DNPEP, MME, DBH FDPS 1561/4885PGR 1587/4885ADRA2A 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.